By measuring 11,000, we can achieve a much more comprehensive understanding of the protein landscape in the plasma, potentially uncovering new biomarkers that were previously unknown or overlooked.”
Peter Schafer, PhD
Scientific Vice President
Bristol Myers Squibb
